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Abstract
Background: Skeletal muscle fibres represent one of the most abundant cell types in mammals. Their highly
specialised contractile and metabolic functions depend on a large number of membrane-associated proteins with
very high molecular masses, proteins with extensive posttranslational modifications and components that exist in
highly complex supramolecular structures. This makes it extremely difficult to perform conventional biochemical
studies of potential changes in protein clusters during physiological adaptations or pathological processes.
Results: Skeletal muscle proteomics attempts to establish the global identification and biochemical characterisation
of all members of the muscle-associated protein complement. A considerable number of proteomic studies have
employed large-scale separation techniques, such as high-resolution two-dimensional gel electrophoresis or liquid
chromatography, and combined them with mass spectrometry as the method of choice for high-throughput
protein identification. Muscle proteomics has been applied to the comprehensive biochemical profiling of
developing, maturing and aging muscle, as well as the analysis of contractile tissues undergoing physiological
adaptations seen in disuse atrophy, physical exercise and chronic muscle transformation. Biomedical investigations
into proteome-wide alterations in skeletal muscle tissues were also used to establish novel biomarker signatures of
neuromuscular disorders. Importantly, mass spectrometric studies have confirmed the enormous complexity of
posttranslational modifications in skeletal muscle proteins.
Conclusions: This review critically examines the scientific impact of modern muscle proteomics and discusses its
successful application for a better understanding of muscle biology, but also outlines its technical limitations and
emerging techniques to establish new biomarker candidates.
Introduction
Proteomics is an unbiased and technology-driven
approach for the comprehensive cataloging of entire
protein complements and represents an ideal analytical
tool for the high-throughput discovery of protein altera-
tions in health and disease [1]. Mass spectrometry-based
proteomics is concerned with the global analysis of pro-
tein composition, posttranslational modifications and
the dynamic nature of expression levels [2-4]. The gen-
eration of large data sets on protein expression levels
makes proteomics a preeminent hypothesis-generating
approach in modern biology [5]. Proteomics has now
been accepted as a key technology in biochemistry, cell
biology, systems biology and drug discovery [6-9]. In
this respect, proteomics suggests itself as a thorough
approach for the detailed biochemical analysis of hetero-
geneous and plastic types of tissue, such as muscles.
Skeletal muscle proteomics aims at the global identifica-
tion, detailed cataloguing and biochemical characterisa-
tion of the entire protein complement of voluntary
contractile tissues in normal and pathological specimens
[10-12]. Although mass spectrometry-based proteomics
is a relatively new analytical approach in the general
field of muscle biology, large-scale proteomic studies
have already provided a plethora of new information on
global changes during myogenesis, fibre maturation,
muscle transformation and natural muscle aging
[12-14]. High-throughput surveys of common neuro-
muscular diseases, such as x-linked muscular dystrophy
[15], have revealed many new proteome-wide changes
and adaptations on the molecular and cellular level [13].
Proteomics routinely employs high-resolution separation
techniques, such as two-dimensional gel electrophoresis
Correspondence: kay.ohlendieck@nuim.ie
Muscle Biology Laboratory, Department of Biology, National University of
Ireland, Maynooth, County Kildare, Ireland
Ohlendieck Skeletal Muscle 2011, 1:6
http://www.skeletalmusclejournal.com/content/1/1/6 Skeletal Muscle
© 2011 Ohlendieck; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.and/or liquid chromatography, in combination with
advanced mass spectrometric methods for the unequivo-
cal identification of peptides and proteins of interest
[16-19]. The independent verification of proteomic data
is usually accomplished by using immunoblotting sur-
veys, activity assays and immunofluorescence micro-
scopic analysis [12]. Over the past few years, technical
advances in mass spectrometry [20-22] and the develop-
ment of vastly improved bioinformatic analysis tools
[23-25] have driven the remarkable progress of proteo-
mic science. This review outlines the findings from
recent applications of mass spectrometry-based proteo-
mics for studying physiological adaptations and patholo-
gical alterations in skeletal muscle tissues and critically
examines novel analytical strategies to establish muscle-
specific biomarker signatures.
The complex biochemistry of skeletal muscle tissues
Contractile fibres of skeletal muscle tissues constitute
the cellular units that provide coordinated excitation-
contraction-relaxation cycles for voluntary movements
and postural control [26]. In addition, skeletal muscles
play a central physiological role in heat homeostasis and
present a crucial metabolic tissue that integrates various
biochemical pathways. For example, skeletal muscle
fibres have the highest capacity for insulin-mediated
uptake of glucose in the body, making muscle tissues a
critical organ in carbohydrate metabolism [27]. The
complex cellular tasks of muscles are performed by a
large number of proteins with specialised functions,
structures and interactions. Skeletal muscles contain a
considerable amount of integral membrane proteins and
high molecular mass complexes. Some of the largest
protein species present in mammalian tissues are
expressed in skeletal muscle, such as nebulin of 600-800
kDa and titin with a molecular mass exceeding 1,200
kDa [28,29]. Although supramolecular membrane
assemblies are also found in many other types of tissue,
notably the nervous system, they represent a major bio-
chemical feature of contractile fibres. This includes the
nicotinic acetylcholine receptor of the postsynaptic mus-
cle membrane [30], the acetylcholinesterase of the basal
lamina [31], the voltage-sensing dihydropyridine recep-
tor of the transverse tubules [32], the ryanodine receptor
Ca
2+-release channel of the triad junctions [33], the dys-
trophin-glycoprotein complex of the sarcolemma [34],
the respiratory chain of muscle mitochondria [35] and
the abundant actomyosin machinery with its regulatory
troponin-tropomyosin system [36]. The large number of
membrane-associated proteins, the exceptionally high
molecular mass of many muscle components, extensive
posttranslational modifications in various muscle pro-
teins and their organisation in highly complex supramo-
lecular structures make it extremely difficult to carry
out conventional biochemical studies of potential
changes in protein clusters during physiological adapta-
tions or pathological processes. In this respect, proteo-
mics and subcellular proteomics attempt to isolate,
separate and identify the entire protein constellation of
a given muscle tissue or fibre population. Most initial
proteomic studies have focused on total extracts of
mostly soluble muscle proteins, and more recent investi-
gations have made an effort to also encompass integral
proteins and high molecular mass components in their
analysis.
Dynamics and heterogeneity of the skeletal muscle
proteome
The biological hierarchy from genome to transcriptome
to proteome is diagrammatically shown in Figure 1. In
contrast to the stable neuromuscular genome, the mus-
cle transcriptome is highly dynamic and the muscle pro-
teome is constantly changing and adapting to altered
functional demands, making its comprehensive analysis
very challenging. The estimated 25,000 protein-coding
genes in the human genome probably translate into sev-
eral hundred thousand different protein species [37].
Although alternative splicing and posttranslational mod-
ifications depend on the exact definition of the term
‘protein isoform’, they result in the production of a very
large number of distinct subspecies of proteins. In mam-
mals, the majority of genes appear to be differentially
s p l i c e d ,s ot h a tas i n g l eg e n eo f t e nc o d e sf o rm u l t i p l e
proteins, which in turn may undergo different types of
posttranslational modifications. A small number of mus-
cle-specific genes can thus generate a large number of
protein species encoded by the muscle genome. An
excellent example of this phenomenon is the family of
sarcoendoplasmic reticulum Ca
2+-ATPase (SERCA)-type
Ca
2+ pumps from slow and fast muscles. Although the
SERCA proteins are encoded by three genes, of which
the SERCA1 and SERCA2 genes are expressed in volun-
tary fibres, the isoform diversity of this abundant ion
pump is drastically increased by alternative splicing of
the transcripts and various posttranslational modifica-
tions [38], producing more than 10 different SERCA
isoforms [39]. These cellular processes significantly
increase muscle protein diversity.
The wide and dynamic expression range of proteins
within a specific tissue makes it impossible to separate
and detect all protein species with currently available
biochemical techniques. In addition, most tissue types
are heterogeneous in composition. Aside from the main
contractile cells of differing contractile properties, such
as slow oxidative (type I), moderately fast oxidative gly-
colytic (type IIa) and fast glycolytic (type IIb) fibres,
muscle contains extended layers of connective tissues,
capillaries and nerve cells [40-42]. Thus the starting
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Figure 1 Biological hierarchy of the neuromuscular system. Shown are the organisation of the genome, transcriptome and proteome of
motor neurons and skeletal muscles. The histological image illustrates neuromuscular junctions on individual muscle fibres labelled for the
presence of the enzyme acetylcholinesterase.
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Page 3 of 15material for almost all invasive biochemical studies, that
is, homogenised muscle tissues, contains a certain
degree of cell types that have originated from the ten-
don, epimysium, endomysium, perimysium, muscle spin-
dles, satellite cells, blood vessels and motor neurons.
This analytical fact has to be taken into account when
one interprets proteomic findings from total tissue
extracts. In the past, microassay systems have been
developed to study single-fibre preparations biochemi-
cally [43], so it might be feasible to investigate such cel-
lular preparations by using miniaturised separation
protocols and proteomic techniques with enhanced sen-
sitivity in the future. Concentration differences between
highly abundant muscle proteins, such as glycolytic
enzymes, and low-abundance muscle proteins, such as
surface signaling receptors, have been estimated to be
several orders of magnitude. Standard gel electrophore-
tic or liquid chromatographic methods are not capable
of separating this vast range of muscle proteins with dif-
fering densities.
Technical limitations of two-dimensional gel
electrophoresis
Besides the biological fact that it is extremely difficult to
accurately define a fixed protein complement in highly
adaptable and dynamic fibre populations as ‘the skeletal
muscle proteome’, the most obvious technical obstacle
to the study of entire muscle proteomes is the limited
availability of all-encompassing protein analytical cap-
abilities. Currently no one set of biochemical techniques
exists that can efficiently separate and consistently
detect the total protein complement of a given cell type.
Hence, with respect to interpreting findings from analy-
tical gel electrophoresis, it is important to take into
account various technical limitations. Two-dimensional
gel electrophoresis of crude tissue extracts usually
underestimates the presence of low abundance elements,
the amount of integral membrane proteins and compo-
nents with very high molecular masses in complex tis-
sues [19,44-46]. In addition, proteins with extreme pI
values are often not properly resolved at the edge of
large gel systems with a wide pI range. This problem
can be partially addressed by using narrow-range pI gels
in the first dimension or by employing overlapping gel
systems covering several pI ranges [44]. Another impor-
tant issue in two-dimensional gel electrophoresis is the
distortion of protein spots due to abundant protein spe-
cies or the presence of isforms with extensive posttran-
slational modifications [45]. For example, high levels of
heterogeneous glycosylation patterns can result in broad
or overlapping spot patterns, which are difficult to pick
for in-gel digestion procedures. Importantly, the pre-
sence of muscle proteins with a high density, such as
myosin heavy chains, myosin light chains, troponins,
tropomyosins and actins, can distort certain zones
within the two-dimensional separation pattern and thus
potentially contaminate other protein spots. In such a
case, the densitometric analysis of a specific spot and
the identification of the most abundant protein species
present in this gel region might not perfectly correlate.
Proteolytic degradation products of high molecular mass
proteins may also complicate the analysis of the gel
image.
However, despite these technical limitations, gel elec-
trophoresis-based proteomics results in excellent cover-
age of soluble and abundant muscle proteins involved
in the regulation and execution of the contraction-
relaxation cycle, energy metabolism and the cellular
stress response [13]. The use of crude tissue extracts as
starting material has the advantage of representing the
entire soluble protein complement without the poten-
tial danger of protein desorption or artefactual entrap-
ment by complex separation steps. On the other hand,
organelle and membrane proteomics reduces sample
complexity by focusing on distinct subsets of protein
populations, as outlined below. Ideally, proteomic stu-
dies of skeletal muscle tissues should first use both
crude extracts and distinct subcellular fractions as
starting material and second employ gel electrophoresis
and liquid chromatography in parallel for the separa-
tion of as many different classes of muscle proteins as
possible.
Mass spectrometry-based muscle proteomics
The long-term goal of proteomic profiling studies is the
cataloguing of all expressed protein species and the
establishment of comprehensive biomarker signatures
that characterise physiological processes during develop-
ment and natural aging, as well as disease progression
in common pathologies. The flowchart in Figure 2 out-
lines the main steps of proteomic profiling studies. The
various steps involved in routine muscle proteomics
involve (1) the extraction of the target protein comple-
ment, resulting in total crude preparations of mostly
soluble components, distinct subcellular fractions
including membrane-associated elements or isolated
complexes; (2) the separation of proteins by one-dimen-
sional gel electrophoresis, high-resolution two-dimen-
sional gel electrophoresis and/or liquid chromatography;
(3) in the case of gel electrophoretic approaches, the
determination of altered expression levels in protein
maps by densitometric surveys; (4) the mass spectro-
metric identification of distinct protein species, usually
by analysing trypsin-generated peptide mixtures of pro-
teins of interest; and (5) the validation of proteomic
data by routine assay systems, such as immunoblotting,
enzyme assays, confocal microscopy, binding assays and
physiological tests.
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Figure 2 Proteomic profiling of skeletal muscle. The flowchart outlines the various preparative and analytical steps involved in the routine
mass spectrometry-based proteomic investigation of contractile tissues. Protein separation is usually carried out by one-dimensional
polyacrylamide gel electrophoresis (1-D PAGE), 2-D gel electrophoresis with isoelectric focusing in the first dimension and PAGE in the second
slab gel dimension (2-D IEF-PAGE) and/or liquid chromatography.
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teomics has successfully catalogued several hundred of
the most abundant and soluble muscle-associated pro-
tein species and identified several thousand distinct pro-
tein isoforms present in skeletal muscle tissues [47-50].
Muscle proteomics has been applied to the comprehen-
sive biochemical profiling of developing, maturing and
aging muscle [51-56], as well as the analysis of contrac-
tile tissues undergoing physiological adaptations seen in
disuse atrophy, physical exercise and chronic muscle
transformation [57-63]. Biomedical investigations into
proteome-wide alterations in skeletal muscle tissues
were also used to establish novel biomarker signatures
of neuromuscular pathologies. Disease-specific markers
were determined for muscle-associated diseases such as
dystrophinopathy [64-66], dysferlinopathy [67], trau-
matic denervation [68], obesity [69], diabetes-related
contractile weakness [70], sepsis [71], hypokalemic myo-
pathy [72], inclusion body myositis [73] and reducing
body myopathy [74]. Since skeletal muscle biology is
highly relevant to the meat industry, muscle proteomics
has been widely applied to cataloguing and studying
protein complements in livestock [75-77]. These studies
have especially focused on the proteomic evaluation of
hypertrophy in chicken [78,79], sheep [80], pig [81-83]
and cow [84] muscles. Table 1 lists key findings from
recent proteomic studies focusing on the biochemical
characterisation of skeletal muscle tissues. Biomarker
signatures are listed only when more than one study has
been conducted on a specific cell biological, physiologi-
cal or pathological topic.
Besides bulk skeletal muscle, refined studies of muscle
subtypes with an unusual histology such as extraocular
muscles have been conducted [66,85], including the pro-
teomic profiling of sarcomere-associated elements [86].
In addition, posttranslational changes were studied in
skeletal muscle preparations by proteomics, focusing
especially on protein nitration [87], carbonylation [88],
glycosylation [89-91] and phosphorylation [92,93]. Com-
prehensive reviews have covered the critical examination
of these proteomic studies [10-15,94,95]. Thus, instead
of recapitulating the considerable impact of these early
studies of muscle proteomics, this review instead out-
lines the more recent application of fluorescent gel elec-
trophoresis, organelle proteomics and membrane
proteomics for studying skeletal muscle tissues.
Fluorescence gel electrophoresis of the muscle proteome
Labeling of proteins with fluorescent dyes has been
extensively applied in proteomic investigations [96-99].
However, the one technique that stands out for its
potential to directly compare two different sets of pro-
tein complements is fluorescence difference in-gel elec-
trophoresis, usually abbreviated as DIGE [100]. This
Table 1 List of select biochemical studies that have focused on the proteomic profiling of developing, transforming,
pathological and aging skeletal muscle tissues
Proteomic study Identification of muscle-specific biomarker signatures References
Skeletal muscle protein
complement
Profiling of the skeletal muscle-associated proteome from various species. Shotgun proteomics
has catalogued more than 2,000 human skeletal muscle proteins.
[47-50]
Muscle development Proteomic analysis of myogenesis has identified a large variety of proteins, including metabolic
enzymes (enolase, aldehyde dehydrogenase), contractile and structural elements (myosins,
actins, tubulin, desmin), stress proteins (peroxiredoxin, superoxide dismutase, heat shock
proteins) and components involved in protein synthesis (ribosomal enzymes).
[51-54,136,137]
Muscle transitions Proteomic studies have established distinct changes in marker characteristic of fast-to-slow
muscle transformations: fatty acid-binding protein, albumin, myosin heavy chains, myosin light
chains, tropomyosins, troponins, creatine kinase and myoglobin.
[62,63]
Effect of exercise Proteomic profiling of physical training showed alterations in enolase, albumin, succinate
dehydrogenase, myoglobin, aconitase and transferrin.
[60,61]
Muscle growth Proteomic analysis of hypertrophy revealed considerable changes in the abundance of
contractile proteins (troponins, myosins), metabolic proteins (fatty acid-binding protein,
phosphoglucomutase) and various molecular chaperones.
[78-84]
Disuse atrophy Proteomic profiling of muscle unloading showed drastic changes in structural and contractile
proteins (myosins, actins, troponins), stress proteins (various heat shock proteins) and marker
enzymes of slow-to-fast transitions (enolase, triosephosphate isomerase, lactate dehydrogenase,
isocitrate dehydrogenase).
[57-59,135]
Dystrophinopathy Proteomic screening of the x-linked muscular dystrophy (mdx) animal model of Duchenne
muscular dystrophy revealed that the deficiency in dystrophin is associated with altered levels
of metabolic enzymes (adenylate kinase, carbonic anhydrase, isocitrate dehydrogenase), Ca
2
+-regulatory proteins (regucalcin, calsequestrin) and molecular chaperones (cardiovascular heat
shock protein cvHsp).
[64-66]
Muscle aging Proteomic profiling of aging muscle tissues has shown changes in metabolic markers that are
characteristic of a fast-to-slow transition process (various glycolytic enzymes, such as pyruvate
kinase and numerous mitochondrial enzymes), as well as changes in adenylate kinase and
various molecular chaperones.
[55,56,87,88,90,92,116,118]
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the most powerful analytical tools for conducting com-
parative protein biochemical investigations [101]. The
fluorescence DIGE technique covers the same type of
proteins as conventional two-dimensional gel electro-
phoretic approaches. If proper labeling protocols are fol-
lowed, the fluorescence tagging procedure does not
significantly interfere with the chemical properties of
proteins with respect to their gel electrophoretic mobi-
lity. Minden et al. [102] first described this two-dimen-
sional gel electrophoretic technique and the first
extensive evaluation of its two-dimensional software
analysis was conducted by Tonge et al. [103]. The DIGE
technique is an ideal method for comparing entire solu-
ble proteomes in one swift analytical approach [100] if
one accepts that proteins with extreme pI values, pro-
teins with a very low density, certain classes of high
molecular mass proteins, extremely hydrophobic pro-
teins and elements with certain posttranslational modifi-
cations may be underrepresented in two-dimensional gel
systems [19,44-46]. DIGE greatly reduces gel-to-gel var-
iations and thereby greatly improves the evaluation of
trends in changed protein expression patterns [104].
The DIGE method has also captured a lot of attention
in the field of skeletal muscle proteomics over the past
few years [55-57,59,63-66]. If the experimental design of
fluorescent studies maximises the sensitivity for detect-
ing changes in protein expression levels and takes into
account statistical variations in dye binding, labelling
artefacts of soluble protein species can be kept to a
minimum [105-107]. Therefore, reverse DIGE labelling
controls are not routinely employed. Dye-to-dye varia-
bility is usually minimal, and the findings from expres-
sion analyses with different dye combinations do not
differ to a large extent. Analytical DIGE systems can be
employed with two-dye or three-dye systems, depending
on specific applications. Advanced DIGE, using an inter-
nal pooled standard, is a highly accurate quantitative
method that enables multiple protein samples to be
separated on the same two-dimensional gel. For exam-
ple, a recent study conducted at our laboratory of the
effects of experimental exon skipping on the dystrophic
diaphragm from the x-linked muscular dystrophy (mdx)
model of Duchenne muscular dystrophy combined the
proteomic profiling of normal versus mdx versus treated
mdx specimens [65]. In one set of six DIGE gels, 12
individual biological replicates of muscle samples were
differentially labelled with different CyDyes Fluors (GE
Healthcare Amersham Biosciences UK, Little Chalfont,
Buckinghamshire, UK) for direct comparison on two-
dimensional gels. A pool of all protein samples was also
prepared and labelled with another CyDye to be
employed as a standard on all gels. A pooled standard
greatly aids image matching and cross-gel statistical
analysis. Ideally, samples are evenly distributed between
both CyDye fluors and analytical gels [65]. Figure 3 out-
lines the use of differential dye labelling for the analysis
of two different muscle specimens. To illustrate the sen-
sitivity of the fluorescent method, an enlarged DIGE
image of distinct changes in the isoform expression pat-
tern of myosin light chain during fast-to-slow muscle
transitions is shown. Our proteomic profiling of fast
muscle following chronic low-frequency stimulation has
been studied by using DIGE analysis, and it clearly
revealed a switch to slower isoforms of myosin light and
heavy chains, as well as increased levels of oxidative
enzymes [63].
Subcellular proteomics of skeletal muscle
Large-scale gel electrophoretic and liquid chromato-
graphic methods have limitations with respect to analys-
ing highly complex protein mixtures and protein
populations with an extensive dynamic expression range.
Thus, to reduce sample complexity, organelle proteomic
studies have been initiated that focus on the protein
complement of distinct subcellular fractions. Organelle
proteomic approaches include sample prefractionation
and the use of narrow pH ranges for the isoelectric
focusing of low copy number proteins in two-dimen-
sional gels as well as in one-dimensional gels for study-
ing hydrophobic and high molecular mass proteins
[108-110]. Reference maps of subcellular fractions from
skeletal muscle include microsomes, sarcolemma, cyto-
sol, contractile apparatus and mitochondria [111-120].
Since mitochondria are involved in various diseases and
cellular aging, many subcellular proteomic studies have
focused on this crucial organelle [121-123]. Proteomic
profiling of the mitochondria-enriched fraction from
senescent rat muscle has revealed a shift to more aero-
bic oxidative metabolism in a slower-twitching fibre
population during age-related muscle degeneration
[118]. This organelle proteomic study has identified
many new potential biomarkers of sarcopenia of old age
[14]. Maughan et al. [111] showed that the 10 glycolytic
enzymes represent the most abundant proteins in the
diffusible fraction of the rabbit skeletal muscle pro-
teome. This makes the key metabolic proteins that med-
iate the core glycolytic pathway ideal candidates to be
studied by using mass spectrometry-based proteomics
[95]. In contrast, organelle-associated proteins are
usually more difficult to identify and characterise. In
this respect, Figure 4 shows a novel approach for study-
ing subcellular fractions by on-membrane digestion of
electrophoretically transferred proteins.
An inefficient trypsination of certain target proteins
often hampers in-gel digestion procedures. To address this
technical problem in the proteomic identification of pro-
teins, on-membrane digestion has been developed
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Figure 3 Overview of the fluorescence difference in-gel electrophoretic (DIGE) method. Shown is a diagram of the differential labeling of
muscle specimens with the fluorescent CyDyes Cy2, Cy3 and Cy5, as well as an example of a DIGE analysis of myosin light chain isoforms
during fast-to-slow transitions of electrostimulated skeletal muscle.
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Page 8 of 15[124-127]. The advantage of on-membrane digestion is
superior protein sequence coverage [124]. In addition, on-
membrane digestion is more efficient and faster compared
with conventional in-gel digestion methods [127]. This
technical fact reduces complications due to trypsin
autolysis and makes the on-membrane digestion technique
especially suitable for the mass spectrometric identification
of low copy number proteins and large hydrophobic pro-
teins. This technique has recently been applied to the bio-
chemical analysis of the large-membrane cytoskeletal
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Figure 4 On-membrane digestion method for muscle proteomics. The flowchart outlines the application of on-membrane digestion for the
mass spectrometric identification of membrane proteins and high molecular mass proteins from skeletal muscle tissues.
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dard two-dimensional gels are usually unable to separate
muscle proteins with a molecular mass greater than 200
kDa [56]. In contrast, one-dimensional gradient gels are
capable of presenting very large membrane proteins up to
2,000 kDa [128]. The mass spectrometric analysis of mus-
cle membranes using one-dimensional gels identified
m e m b r a n e - a s s o c i a t e dm u s c l ep r o t e i n sa sw e l la st h e
Dp427 isoform of dystrophin, including the dihydropyri-
dine receptor of the transverse tubules and the 565-kDa
ryanodine receptor Ca
2+-release channel of the junctional
sarcoplasmic reticulum [120]. On-membrane digestion
was demonstrated to be highly suitable for studying high
molecular mass proteins that would otherwise not be
properly recognised by gel electrophoresis-based proteo-
mic studies. Muscle proteins adsorbed onto nitrocellulose
sheets appear to be more accessible to proteases, increas-
ing digestion efficiency [120]. This makes this novel tech-
nique the method of choice for studying large membrane
proteins.
Since membrane proteins play a crucial role in cellular
signaling, regulation, homeostasis and metabolism, the
large-scale identification and characterisation of periph-
eral and integral membrane proteomics is an important
aspect of modern proteomics [129-131]. Recently, deter-
gent phase extraction was applied to the proteomic analy-
sis of the membrane-associated fraction from skeletal
muscle [132]. This method is based on the principle of
temperature-dependent phase extraction with Triton X-
114. Since phase separation with this nonionic detergent
occurs at temperatures above 22°C, skeletal muscle pro-
tein fractionation was carried out at 37°C [132]. As out-
lined in the flowchart in Figure 5, the separation step
resulted in an aqueous phase enriched in hydrophilic pro-
teins and a detergent phase with predominantly hydro-
phobic proteins. However, phase transition approaches
always result in a certain degree of cross-contamination
between soluble and membrane-associated proteins. The
partitioning and cross-contamination of hydrophobic ver-
sus hydrophilic protein populations can be conveniently
monitored by immunoblotting (Figure 5).
Emerging technologies for muscle proteomics
Mass spectrometry-based proteomics is a fast-moving
field with a variety of emerging technologies that have
not yet been fully exploited in the field of skeletal mus-
cle proteomics. Although several studies on muscle cells
have included quantification methods involving the
incorporation of stable isotopes through metabolic or
chemical labelling [53,61,82,133-135], as well as through
label-free shotgun proteomics [50,51,85,136,137], future
applications of a variety of advanced gel-free techniques
promise an even greater impact of proteomics on mus-
cle biology and biomarker discovery. The advantages
and technical challenges of label-free proteomics versus
the use of stable isotopes for metabolic or chemical
labelling have been extensively outlined in several excel-
lent reviews [4,138-140]. Numerous stable isotope-label-
ling techniques have been employed in quantitative
shotgun proteomics, including isobaric tags for relative
and absolute quantification, or iTRAQ; isotope-coded
affinity tag, or ICAT; and stable isotope labelling by
amino acids in cell culture, or SILAC. In skeletal muscle
proteomics, the SILAC method was successfully applied
to the quantitative profiling of differential protein
expression between myoblasts and myotubes [53] and
the identification of proteins that interact with the glu-
cose transporter GLUT4 in an insulin-regulated manner
[133]. The ICAT labelling approach has been used for
the proteomic profiling of the cytosolic fraction from
atrophying mouse tibialis anterior muscle [135]. The
iTRAQ technique was employed for the analysis of
changes in the protein complement of human vastus
lateralis muscle in response to interval exercise training
[61], the cataloguing of the skeletal muscle proteome
from pigs [82] and the identification of carbonylated
proteins from rat muscle mitochondria [134].
In future proteomic shotgun experiments, protein
populations from skeletal muscle tissues could be pro-
filed by label-free quantification approaches such as pep-
tide spectral counts. The term spectral counts refers to
the number of mass spectrometry (MS)/MS identifica-
tions per protein species. Since abundant peptide species
are detectable across a wide period of retention time
and are therefore repeatedly sampled, a linear relation-
ship exists between protein concentration and spectral
counts [141]. This makes identification results from
MS/MS spectra an attractive option for quantitative
shotgun proteomics. With respect to the validation of
protein biomarkers, stable isotope dilution (SID)-MS
might be a useful addition to the analytical repertoire of
muscle proteomics. This technique is especially useful
for the characterisation of low-abundance biomarkers.
Multiple reaction monitoring (MRM) coupled with
SID-MS represents an ideal method for the quantitative
measurement of low-abundance biomarkers [142]. In
SID-MRM-MS investigations, the quantification of a
biomarker protein of interest is achieved by selecting
signature peptides of the digested target protein [143].
Unique signature peptides are employed as quantitative
substitutes of the marker protein. The concentration of
the biomarker protein can be determined by comparing
the signals from the exogenous SID-labelled signature
peptide and the endogenous unlabelled peptide popu-
lation [144].
To tackle the technical challenges associated with ana-
lysing membrane proteins, an exciting universal sample
preparation method has been developed: filter-aided
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Figure 5 Detergent phase extraction method for muscle proteomics. The flowchart outlines the application of detergent phase extraction
for the mass spectrometric identification of membrane-associated proteins from skeletal muscle tissues. The separation of protein species into an
aqueous (AQ) fraction versus a detergent (DT) fraction can be conveniently verified by immunoblotting with antibodies to soluble versus integral
markers.
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Page 11 of 15sample preparation (FASP). On the basis of the fact that
membrane proteins can be depleted of detergent by gel
filtration in 8 M urea [145], Wisniewski et al. [146]
established a proteomic sample preparation technique
based on the complete solubilisation of a protein com-
plement in 4% sodium dodecyl sulphate and subsequent
exchange of detergent by urea on spin filter devices.
The FASP method depletes the suspension of low mole-
cular mass components in urea-containing buffer,
digests a representative cohort of proteins including
hydrophobic elements and elutes pure peptide mixtures
[146]. Thus, FASP is an ideal tool to be applied to the
proteomic identification and characterisation of high
molecular mass membrane proteins from skeletal mus-
cle, because peptide mixtures eluted after digestion on
the spin filter were highly suitable for mass spectro-
metric analysis [146]. Since a large number of hydro-
phobic proteins are involved in physiological adaptations
and pathological changes in contractile fibres, this new
universal sample preparation tool promises to be extre-
mely useful for future proteomic investigations of mus-
cle organelles.
Conclusions
Over the past few years, skeletal muscle proteomics has
successfully catalogued the majority of abundant and
soluble fibre-associated proteins. The refined proteomic
analysis of isoform expression patterns and biochemical
studies of dynamic posttranslational modifications has
identified thousands of distinct muscle protein species.
Myogenesis, muscle maturation, muscle transformation
and aging-related muscle wasting have been intensively
investigated by using proteomic methods and has resulted
in the establishment of a comprehensive biomarker
signature for major physiological adaptation processes in
contractile tissues. The proteomic characterisation of
common neuromuscular disorders has revealed novel dis-
ease-specific marker proteins of disuse atrophy, muscular
dystrophy, obesity, type 2 diabetes, sepsis, hypokalemic
myopathy, inclusion body myositis and reducing body
myopathy. Thus, MS-based proteomics has decisively
improved our general understanding of physiological and
pathophysiological mechanisms in muscle tissues. New
biomarker candidates can now be used for improving
diagnostic methods, the identification of novel therapeutic
targets, better comprehension of the molecular pathogen-
esis of muscular disorders, improved monitoring of dis-
ease progression and the judging of potential side effects
of experimental drugs. Importantly, if the proteomic
workflow could be successfully miniaturised, then single-
cell proteomics of different fibre populations would lead
to more comprehensive coverage of the skeletal muscle
proteome. This depends on technical developments in
the field of MS [20-22]. In the future, organelle and
membrane proteomics will probably play a more promi-
nent role in muscle biochemistry to study less abundant
and more hydrophobic proteins. Filter-aided sample pre-
paration and on-membrane digestion may be preferred
for the proteomic analysis of high molecular mass mem-
b r a n ep r o t e i n s .O n c et h em a j o r i t yo fl a r g ea n di n t e g r a l
muscle proteins have been catalogued by proteomics, it
will be crucial to correlate these findings with genomic,
transcriptomic and metabolomic databanks [147] and
establish the global relationship of biomolecules in
striated voluntary muscle tissues.
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